The Endocrine Society
FDANonrulemakingFDA-2012-N-0171

Using Innovative Technologies and Other Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription

RIN
Last modified
Jan 22, 2013
Comment window
closed 5195d ago
The Endocrine Society filings
1

Activity

The Endocrine Society filed 1 comment on this docket between Mar 27, 2012 and Mar 27, 2012. 21 other organizations filed here. The comment window closed 5195d ago.

What The Endocrine Society filed (1)

Mar 27, 2012· The Endocrine Society - Comment· FDA-2012-N-0171-0012

Filed on regulations.gov — full text not in the inline record.

Abstract

No abstract recorded.

View on regulations.gov →